Activation of Caspase Pathways during Iron Chelator-mediated Apoptosis
Open Access
- 1 July 2002
- journal article
- Published by Elsevier
- Vol. 277 (28), 25568-25575
- https://doi.org/10.1074/jbc.m110345200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: the mechanisms involved in inhibiting cell-cycle progressionBlood, 2001
- Gene expression analysis in N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R‐apomorphineJournal of Neurochemistry, 2001
- Iron and neurodegenerative disordersBrain Research Bulletin, 2001
- Iron chelation: New therapiesSeminars in Hematology, 2001
- The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H2O2 injury in adult cardiomyocytesCardiovascular Research, 2000
- Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell linesCarcinogenesis: Integrative Cancer Research, 2000
- ANTIVIRAL AND IMMUNOMODULATORY EFFECTS OF DESFERRIOXAMINE IN CYTOMEGALOVIRUS-INFECTED RAT LIVER ALLOGRAFTS WITH REJECTION1Transplantation, 1999
- Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase‐3Cell Proliferation, 1999
- Tumor Cell Cytotoxicity of a Novel Metal ChelatorBlood, 1998
- Iron chelators induce apoptosis in proliferating cellsBritish Journal of Haematology, 1995